Abstract
The diversity of glycan presentation in a cell, tissue and organism is enormous, which reflects the huge amount of important biological information encoded by the glycome which has not been fully understood. A compelling body of evidence has been highlighting the fundamental role of glycans in immunity, such as in development, and in major inflammatory processes such as inflammatory bowel disease, systemic lupus erythematosus and other autoimmune disorders. Glycans play an instrumental role in the immune response, integrating the canonical circuits that regulate innate and adaptive immune responses. The relevance of glycosylation in immunity is demonstrated by the role of glycans as important danger-associated molecular patterns and pathogen-associated molecular patterns associated with the discrimination between self and non-self; also as important regulators of the threshold of T cell activation, modulating receptors signalling and the activity of both T and other immune cells. In addition, glycans are important determinants that regulate the dynamic crosstalk between the microbiome and immune response. In this chapter, the essential role of glycans in the immunopathogenesis of inflammatory disorders will be presented and its potential clinical applications (diagnosis, prognosis and therapeutics) will be highlighted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ablasser A, Chen ZJ (2019) cGAS in action: expanding roles in immunity and inflammation. Science 363:eaat8657
Afzali AM, Müntefering T, Wiendl H et al (2018) Skeletal muscle cells actively shape (auto)immune responses. Autoimmun Rev 17:518–529
Alves I, Pinto V, Santos-Pereira B et al (2020) AB0123 changes in cellular glycosylation as a key factor in the immunopathogenesis of systemic lupus erythematosus. Ann Rheum Dis 79BMJ Publishing Group Ltd:1361–1362
Amin R, Mourcin F, Uhel F et al (2015) DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma. Blood 126:1911–1920
Annese V, Piepoli A, Perri F et al (2004) Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Aliment Pharmacol Ther 20:1143–1152
Araujo L, Khim P, Mkhikian H et al (2017) Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. Elife 6
Arnold JN, Wormald MR, Sim RB et al (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25:21–50
Bain CC, Mowat AM (2014) Macrophages in intestinal homeostasis and inflammation. Immunol Rev 260:102–117. https://doi.org/10.1111/imr.12192
Barbosa JA, Santos-Aguado J, Mentzer SJ et al (1987) Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition. J Exp Med 166:1329–1350. https://doi.org/10.1084/jem.166.5.1329
Bax M, García-Vallejo JJ, Jang-Lee J et al (2007) Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins. J Immunol 179:8216–8224
Beccaria CG, Amezcua Vesely MC, Fiocca Vernengo F et al (2018) Galectin-3 deficiency drives lupus-like disease by promoting spontaneous germinal centers formation via IFN-γ. Nat Commun 9:1628
Bogdanos DP, Rigopoulou EI, Smyk DS et al (2011) Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn’s disease specific-pancreatic autoantibodies. Autoimmun Rev 11:143–148
Broccolini A, Gidaro T, Morosetti R, Mirabella M (2009) Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy. Muscle Nerve 40:340–349. https://doi.org/10.1002/mus.21385
Brown GD, Willment JA, Whitehead L (2018) C-type lectins in immunity and homeostasis. Nat Rev Immunol 18:374–389
Burrows PD, Stephan RP, Wang Y-H et al (2002) The transient expression of pre-B cell receptors governs B cell development. Semin Immunol 14:343–349
Cabral J, Hanley SA, Gerlach JQ et al (2017) Distinctive surface glycosylation patterns associated with mouse and human CD4+ regulatory T cells and their suppressive function. Front Immunol 8:987
Cai M, Zhou T, Wang X et al (2016) DC-SIGN expression on podocytes and its role in inflammatory immune response of lupus nephritis. Clin Exp Immunol 183:317–325
Chen H-L, Li CF, Grigorian A et al (2009a) T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching. J Biol Chem 284:32454–32461. https://doi.org/10.1074/jbc.M109.023630
Chen H-Y, Fermin A, Vardhana S et al (2009b) Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse. Proc Natl Acad Sci U S A 106:14496–14501
Chen H-Y, Wu Y-F, Chou F-C et al (2020) Intracellular Galectin-9enhances proximal TCR signaling and potentiates autoimmune diseases. J Immunol 204:1158–1172
Chui D, Sellakumar G, Green R et al (2001) Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci U S A 98:1142–1147
Clerc F, Novokmet M, Dotz V et al (2018) Plasma N-glycan signatures are associated with features of inflammatory bowel diseases. Gastroenterology 155:829–843
Comber JD, Philip R (2014) MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines. Ther Adv Vaccine 2:77–89
Connelly MA, Otvos JD, Shalaurova I et al (2017) GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. J Transl Med 15:219
Daniels MA, Devine L, Miller JD et al (2001) CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15:1051–1061
Demetriou M, Granovsky M, Quaggin S, Dennis JW (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409:733–739
den Haan JMM, Arens R, van Zelm MC (2014) The activation of the adaptive immune system: cross-talk between antigen-presenting cells, T cells and B cells. Immunol Lett 162:103–112
Dias AM, Dourado J, Lago P et al (2014) Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis. Hum Mol Genet 23:2416–2427
Dias AM, Correia A, Pereira MS et al (2018a) Metabolic control of T cell immune response through glycans in inflammatory bowel disease. Proc Natl Acad Sci U S A 115:E4651–E4660
Dias AM, Pereira MS, Padrão NA et al (2018b) Glycans as critical regulators of gut immunity in homeostasis and disease. Cell Immunol 333:9–18
Dierckx T, Verstockt B, Vermeire S, van Weyenbergh J (2019) GlycA, a nuclear magnetic resonance spectroscopy measure for protein glycosylation, is a viable biomarker for disease activity in IBD. J Crohns Colitis 13:389–394
Drake PM, Stock CM, Nathan JK et al (2009) Polysialic acid governs T-cell development by regulating progenitor access to the thymus. Proc Natl Acad Sci U S A 106:11995–12000
Dubé R, Rook GA, Steele J et al (1990) Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut 31:431–434
Ercan A, Cui J, Chatterton DEW et al (2010) Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 62:2239–2248
Espeli M, Mancini SJC, Breton C et al (2009) Impaired B-cell development at the pre-BII-cell stage in galectin-1–deficient mice due to inefficient pre-BII/stromal cell interactions. Blood 113:5878–5886
Feagan BG, Rutgeerts P, Sands BE et al (2013) Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 369:699–710
Ferwerda B, Ferwerda G, Plantinga TS et al (2009) Human dectin-1deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760. https://doi.org/10.1056/NEJMOA0901053
Frol’ová L, Smetana K, Borovská D et al (2009) Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? Inflamm Res 58:503–512. https://doi.org/10.1007/s00011-009-0016-8
Fu J, Wei B, Wen T et al (2011) Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest 121:1657–1666
Galvan M, Tsuboi S, Fukuda M, Baum LG (2000) Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J Biol Chem 275:16730–16737
Gauthier L, Smith KJ, Pyrdol J et al (1998) Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein. Proc Natl Acad Sci U S A 95:11828–11833
Gauthier L, Rossi B, Roux F et al (2002) Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci U S A 99:13014–13019
Gordon FH, Lai CW, Hamilton MI et al (2001) A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn’s disease. Gastroenterology 121:268–274
Gordon FH, Hamilton MI, Donoghue S et al (2002) A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. Aliment Pharmacol Ther 16:699–705
Goto Y, Obata T, Kunisawa J et al (2014) Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345:1254009
Grigorian A, Lee S-U, Tian W et al (2007) Control of T cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis. J Biol Chem 282:20027–20035
Grigorian A, Torossian S, Demetriou M (2009) T-cell growth, cell surface organization, and the galectin-glycoprotein lattice. Immunol Rev 230:232–246
Hanić M, Trbojević-Akmačić I, Lauc G (2019) Inflammatory bowel disease – glycomics perspective. Biochim Biophys Acta Gen Subj 1863:1595–1601
Hardy RR, Hayakawa K (2001) B cell development pathways. Annu Rev Immunol 19:595–621
Hewitt EW (2003) The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110:163–169
Hokama A, Mizoguchi E, Sugimoto K et al (2004) Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20:681–693
Hollmig ST, Ariizumi K, Cruz PD (2009) Recognition of non-self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2. Glycobiology 19:568–575
Hooper LV, Gordon JI (2001) Commensal host-bacterial relationships in the gut. Science 292:1115–1118
Hovhannisyan Z, Treatman J, Littman DR, Mayer L (2011) Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140:957–965
Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327:291–295
Kansas G (1996) Selectins and their ligands: current concepts and controversies. Blood 88:3259–3287
Kaplan GG, Ng SC (2017) Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152:313–321.e2
Koch U, Radtke F (2011) Mechanisms of T cell development and transformation. Annu Rev Cell Dev Biol 27:539–562
Koch U, Lacombe TA, Holland D et al (2001) Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. Immunity 15:225–236
Koropatkin NM, Cameron EA, Martens EC (2012) How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10:323–356
Larsson JMH, Karlsson H, Crespo JG et al (2011) Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis 17:2299–2307
Lee MY, Jeon JW, Sievers C, Allen CT (2020) Antigen processing and presentation in cancer immunotherapy. J Immunother Cancer 8:e001111
Lewis ZT, Totten SM, Smilowitz JT et al (2015) Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome 3:13
Lhotta K, Würzner R, König P (1999) Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrol Dial Transplant 14:881–886
Li X, Conklin L, Alex P (2008) New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 14:5115–5124
Li W, Liu Q, Pang Y et al (2012) Core fucosylation of μ heavy chains regulates assembly and intracellular signaling of precursor B cell receptors. J Biol Chem 287:2500–2508
Lood C, Allhorn M, Lood R et al (2012) IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment? Arthritis Rheum 64:2698–2706
Lugo-Villarino G, Troegeler A, Balboa L et al (2018) The C-type lectin receptor DC-SIGN has an anti-inflammatory role in human M(IL-4) macrophages in response to Mycobacterium tuberculosis. Front Immunol 9:1123
Ma BY, Mikolajczak SA, Yoshida T et al (2004) CD28 T cell costimulatory receptor function is negatively regulated by N-linked carbohydrates. Biochem Biophys Res Commun 317:60–67
Madireddi S, Eun S-Y, Lee S-W et al (2014) Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J Exp Med 211:1433–1448
Malicdan MCV, Noguchi S, Hayashi YK et al (2009) Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 15:690–695
Marth JD, Grewal PK (2008) Mammalian glycosylation in immunity. Nat Rev Immunol 8:874–887
McMorran BJ, McCarthy FE, Gibbs EM et al (2016) Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx. Glycobiology 26:1120–1132
Mesin L, Ersching J, Victora GD (2016) Germinal center B cell dynamics. Immunity 45:471–482
Miller JFAP (2020) The function of the thymus and its impact on modern medicine. Science (80-) 369:eaba2429
Miller FW, Lamb JA, Schmidt J, Nagaraju K (2018) Risk factors and disease mechanisms in myositis. Nat Rev Rheumatol 14:255–268
Mkhikian H, Grigorian A, Li CF et al (2011) Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun 2:334
Modenutti CP, Capurro JIB, Di Lella S, Martí MA (2019) The structural biology of galectin-ligand recognition: current advances in modeling tools, protein engineering, and inhibitor design. Front Chem 7:823
Momozawa Y, Dmitrieva J, Théâtre E et al (2018) IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nat Commun 9:2427
Moody AM, Chui D, Reche PA et al (2001) Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding. Cell 107:501–512
Morgan R, Gao G, Pawling J et al (2004) N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol 173:7200–7208
Mortales C-L, Lee S-U, Demetriou M (2020) N-glycan branching is required for development of mature B cells. J Immunol 205:630–636
Mourcin F, Breton C, Tellier J et al (2011) Galectin-1–expressing stromal cells constitute a specific niche for pre-BII cell development in mouse bone marrow. Blood 117:6552–6561
Nakayama K, Wakamatsu K, Fujii H et al (2019) Core fucose is essential glycosylation for CD14-dependent Toll-like receptor 4 and Toll-like receptor 2 signalling in macrophages. J Biochem 165:227–237
Neefjes J, Jongsma MLM, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823–836
Neill DR, Flynn RJ (2018) Origins and evolution of innate lymphoid cells: Wardens of barrier immunity. Parasite Immunol 40:e12436
Nemazee D (2017) Mechanisms of central tolerance for B cells. Nat Rev Immunol 17:281–294
Nio-Kobayashi J (2018) Histological mapping and subtype-specific functions of galectins in health and disease. Trend Glycosci Glycotechnol 30:SJ47–SJ53
Obino D, Fetler L, Soza A et al (2018) Galectin-8favors the presentation of surface-tethered antigens by stabilizing the B cell immune synapse. Cell Rep 25:3110–3122.e6
Oliveira-de-Abreu E, Silva-dos-Santos D, Lepletier A et al (2018) Lack of galectin-3disrupts thymus homeostasis in association to increase of local and systemic glucocorticoid levels and steroidogenic machinery. Front Endocrinol (Lausanne) 9:365
Omenetti S, Pizarro TT (2015) The Treg/Th17 axis: adynamic balance regulated by the gut microbiome. Front Immunol 6:639
Ostankovitch M, Altrich-Vanlith M, Robila V, Engelhard VH (2009) N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. J Immunol 182:4830–4835
Paclik D, Berndt U, Guzy C et al (2008) Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med (Berl) 86:1395–1406
Parsons MW, Li L, Wallace AM et al (2014) Dectin-2regulates the effector phase of house dust mite–elicited pulmonary inflammation independently from its role in sensitization. J Immunol 192:1361–1371
Pereira MS, Alves I, Vicente M et al (2018a) Glycans as key checkpoints of T cell activity and function. Front Immunol 9:2754
Pereira MS, Maia L, Azevedo LF et al (2018b) A [Glyco]biomarker that predicts failure to standard therapy in ulcerative colitis patients. J Crohns Colitis 13:39–49
Pereira MS, Durães C, Catarino TA et al (2020) Genetic variants of the MGAT5gene are functionally implicated in the modulation of T cells glycosylation and plasma IgG glycome composition in ulcerative colitis. Clin Transl Gastroenterol 11:e00166
Perillo NL, Uittenbogaart CH, Nguyen JT, Baum LG (1997) Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med 185:1851–1858
Petrosyan A, Cravedi P, Villani V et al (2019) A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier. Nat Commun 10:3656
Pillai S, Cariappa A (2009) The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 9:767–777
Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417–429
Rabinovich GA, Toscano MA (2009) Turning “sweet” on immunity: galectin–glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 9:338–352
Rampal R, Li ASY, Moloney DJ et al (2005) Lunatic fringe, manic fringe, and radical fringe recognize similar specificity determinants in O-fucosylated epidermal growth factor-like repeats. J Biol Chem 280:42454–42463
Rausch P, Rehman A, Künzel S et al (2011) Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci U S A 108:19030–19035
Ravcheev DA, Thiele I (2017) Comparative genomic analysis of the human gut microbiome reveals a broad distribution of metabolic pathways for the degradation of host-synthetized mucin glycans and utilization of mucin-derived monosaccharides. Front Genet 8:111
Reily C, Stewart TJ, Renfrow MB, Novak J (2019) Glycosylation in health and disease. Nat Rev Nephrol 15:346–366
Roche PA, Furuta K (2015) The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol 15:203–216
RodrÍguez E, Schetters STT, van Kooyk Y (2018) The tumour glyco-code as a novel immune checkpoint for immunotherapy. Nat Rev Immunol 18:204–211
Rossi FMV, Corbel SY, Merzaban JS et al (2005) Recruitment of adult thymic progenitors is regulated by P-selectin and its ligand PSGL-1. Nat Immunol 6:626–634
Ruel J, Ruane D, Mehandru S et al (2014) IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 11:88–98
Ryan SO, Cobb BA (2012) Host glycans and antigen presentation. Microbes Infect 14:894–903
Ryan SO, Bonomo JA, Zhao F, Cobb BA (2011) MHCII glycosylation modulates Bacteroides Fragiliscarbohydrate antigen presentation. J Exp Med 208:1041–1053
Salvatore S, Heuschkel R, Tomlin S et al (2000) A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Aliment Pharmacol Ther 14:1567–1579
Samardzic T, Marinkovic D, Danzer C-P et al (2002) Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol 32:561–567
Sandborn WJ, Feagan BG, Rutgeerts P et al (2013) Vedolizumab as induction and maintenance therapy for Crohn’s disease. N Engl J Med 369:711–721
Schatz DG, Ji Y (2011) Recombination centres and the orchestration of V(D)J recombination. Nat Rev Immunol 11:251–263
Schnaar RL (2016) Glycobiology simplified: diverse roles of glycan recognition in inflammation. J Leukoc Biol 99:825–838
Seidelin JB, Vainer B, Horn T, Nielsen OH (1998) Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease. Am J Gastroenterol 93:1854–1859
Shah DK, Zúñiga-Pflücker JC (2014) An overview of the intrathymic intricacies of T cell development. J Immunol 192:4017–4023
Shih H-Y, Hao B, Krangel MS (2011) Orchestrating T-cell receptor α gene assembly through changes in chromatin structure and organization. Immunol Res 49:192–201
Shinzaki S, Iijima H, Nakagawa T et al (2008) IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Am J Gastroenterol 103:1173–1181
Shinzaki S, Ishii M, Fujii H et al (2016) N-Acetylglucosaminyltransferase V exacerbates murine colitis with macrophage dysfunction and enhances colitic tumorigenesis. J Gastroenterol 51:357–369
Šimurina M, de Haan N, Vučković F et al (2018) Glycosylation of immunoglobulin G associates with clinical features of inflammatory bowel diseases. Gastroenterology 154:1320–1333.e10
Song Y, Kumar V, Wei H-X et al (2016) Lunatic, manic, and radical fringe each promote T and B cell development. J Immunol 196:232–243
Sperandio M (2006) Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J 273:4377–4389
Stanley P, Guidos CJ (2009) Regulation of Notch signaling during T- and B-cell development by O -fucose glycans. Immunol Rev 230:201–215
Storni T, Bachmann MF (2004) Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison. J Immunol 172:6129–6135
Sultana DA, Zhang SL, Todd SP, Bhandoola A (2012) Expression of functional P-selectin glycoprotein ligand 1 on hematopoietic progenitors is developmentally regulated. J Immunol 188:4385–4393
Tailford LE, Crost EH, Kavanaugh D, Juge N (2015) Mucin glycan foraging in the human gut microbiome. Front Genet 6:81
Takaba H, Takayanagi H (2017) The mechanisms of T cell selection in the thymus. Trends Immunol 38:805–816
Takeuchi H, Yu H, Hao H et al (2017) O-glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates Notch trafficking. J Biol Chem 292:15964–15973
Theodoratou E, Campbell H, Ventham NT et al (2014) The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 11:588–600
Togayachi A, Kozono Y, Ishida H et al (2007) Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation. Proc Natl Acad Sci U S A 104:15829–15834
Toscano MA, Bianco GA, Ilarregui JM et al (2007) Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8:825–834
Townsend D (2014) Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex. Anat Rec 297:1694–1705
Trbojević Akmačić I, Ventham NT, Theodoratou E et al (2015) Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm Bowel Dis 21:1237–1247
Tribulatti MV, Cattaneo V, Hellman U et al (2009) Galectin-8 provides costimulatory and proliferative signals to T lymphocytes. J Leukoc Biol 86:371–380
Trombetta ES, Helenius A (1998) Lectins as chaperones in glycoprotein folding. Curr Opin Struct Biol 8:587–592
Tsai C-M, Guan C-H, Hsieh H-W et al (2011) Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation. J Immunol 187:1643–1652
Übelhart R, Bach MP, Eschbach C et al (2010) N-linked glycosylation selectively regulates autonomous precursor BCR function. Nat Immunol 11:759–765
Unanue ER, Turk V, Neefjes J (2016) Variations in MHC class II antigen processing and presentation in health and disease. Annu Rev Immunol 34:265–297. https://doi.org/10.1146/annurev-immunol-041015-055420
Varki A, Gagneux P (2012) Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 1253:16–36
Verhelst X, Dias AM, Colombel J-F et al (2020) Protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases. Gastroenterology 158:95–110
Videira PA, Amado IF, Crespo HJ et al (2008) Surface alpha 2-3- and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J 25:259–268. https://doi.org/10.1007/s10719-007-9092-6
Vivier E, Artis D, Colonna M et al (2018) Innate lymphoid cells: 10years on. Cell 174:1054–1066
Vučković F, Krištić J, Gudelj I et al (2015) Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol (Hoboken, NJ) 67:2978–2989
Wang Y, Tan J, Sutton-Smith M et al (2001) Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 11:1051–1070
Webster P, Pusey C (2017) Crescentic glomerulonephritis: beyond the immune system. Nat Rev Nephrol 13:198–200
Wiendl H, Hohlfeld R, Kieseier BC (2005) Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol 26:373–380
Wu C, Thalhamer T, Franca RF et al (2014) Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity 41:270–282
Yu TB, Dodd S, Yu L-G, Subramanian S (2020) Serum galectins as potential biomarkers of inflammatory bowel diseases. PLoS One 15:e0227306
Zarbock A, Ley K, McEver RP, Hidalgo A (2011) Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood 118:6743–6751
Zeng J, Eljalby M, Aryal RP et al (2020) Cosmc controls B cell homing. Nat Commun 11:3990
Zhou RW, Mkhikian H, Grigorian A et al (2014) N-glycosylation bidirectionally extends the boundaries of thymocyte positive selection by decoupling Lck from Ca2+ signaling. Nat Immunol 15:1038–1045
Zhou G, Song Y, Yang W et al (2016) ASCA, ANCA, ALCA and many more: are they useful in the diagnosis of inflammatory bowel disease? Dig Dis 34:90–97
Zhu C, Anderson AC, Schubart A et al (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6:1245–1252
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Alves, I. et al. (2021). The Role of Glycosylation in Inflammatory Diseases. In: Lauc, G., Trbojević-Akmačić, I. (eds) The Role of Glycosylation in Health and Disease. Advances in Experimental Medicine and Biology, vol 1325. Springer, Cham. https://doi.org/10.1007/978-3-030-70115-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-70115-4_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-70114-7
Online ISBN: 978-3-030-70115-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)